Tech Center 1600 • Art Units: 1626
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18010642 | COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING AUTOPHAGY | Final Rejection | President and Fellows of Harvard College |
| 17642662 | CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 17742378 | COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | Final Rejection | FUJIFILM Corporation |
| 13895089 | NOVEL BICYCLIC HETEROCYCLIC COMPOUND | Final Rejection | SUMITOMO PHARMA CO., LTD. |
| 17927762 | BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS | Final Rejection | CHIESI FARMACEUTICI S.P.A. |
| 18261629 | KRAS G12C INHIBITORS | Non-Final OA | BeiGene Switzerland GmbH |
| 17369032 | UBE2K MODULATORS AND METHODS FOR THEIR USE | Final Rejection | BPGbio, Inc. |
| 17964423 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | Non-Final OA | BioSplice Therapeutics, Inc. |
| 17972008 | PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN) | Final Rejection | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. |
| 18258675 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | Non-Final OA | ACTELION PHARMACEUTICALS LTD |
| 18274867 | NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF | Non-Final OA | TXINNO BIOSCIENCE INC. |
| 18260004 | TRICYCLIC COMPOUND AND USE THEREOF | Non-Final OA | NANJING ZAIMING PHARMACEUTICAL CO., LTD. |
| 17764329 | INHIBITOR OF BTK AND MUTANTS THEREOF | Final Rejection | Newave Pharmaceutical Inc. |
| 18129310 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | Non-Final OA | LT MATERIALS CO., LTD. |
| 17998234 | COMPOUNDS AS BCL-2 INHIBITORS | Non-Final OA | Fochon Biosciences, Ltd. |
| 17768725 | ERGOLINE-LIKE COMPOUNDS FOR PROMOTING NEURAL PLASTICITY | Final Rejection | Delix Therapeutics, Inc. |
| 17926900 | COMPOUND AND APPLICATION THEREOF | Non-Final OA | GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD |
| 17802886 | INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF CORONAVIRAL INFECTIONS | Non-Final OA | Immunologik GmbH |
| 17915474 | FLUORESCENT LABELING AGENT AND FLUORESCENT DYE | Non-Final OA | artience Co., Ltd. |
| 17759807 | PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND | Final Rejection | FRONTIER BIOTECHNOLOGIES INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy